A research laboratory is developing a novel diagnostic assay for early detection of sepsis. They are investigating the use of host biomarkers that are rapidly upregulated in response to bacterial infection. Which of the following biomarkers has shown promise for differentiating between systemic inflammatory response syndrome (SIRS) and sepsis?

• A. Erythrocyte sedimentation rate (ESR)
• B. Procalcitonin (PCT)
• C. Interleukin-6 (IL-6)
• D. C-reactive protein (CRP)

A research team is investigating the mechanisms of antifungal resistance in Candida albicans. They identify a strain that exhibits resistance to azole antifungal agents. Further analysis reveals overexpression of a specific ATP-binding cassette (ABC) transporter protein in the resistant strain. This mechanism of resistance involves:

• A. Modification of the fungal cell wall, preventing azole penetration.
• B. Alteration of the fungal ergosterol biosynthesis pathway, the target of azoles.
• C. Active efflux of the azole antifungal agent out of the fungal cell.
• D. Increased degradation of the azole antifungal agent within the fungal cell.

A patient with severe combined immunodeficiency (SCID) develops a progressive respiratory illness.
Bronchoalveolar lavage fluid is examined using direct fluorescent antibody (DFA) staining, which reveals numerous cysts of Pneumocystis jirovecii. The cysts appear:

• A. Oval-shaped with a thin wall and internal nuclei.
• B. Large and multinucleated with prominent endospores.
• C. Small and round with a thick wall, containing sporozoites.
• D. Cup-shaped or helmet-shaped with internal structures.

A clinical microbiology laboratory is validating a new multiplex PCR assay for the simultaneous detection of several gastrointestinal pathogens, including Salmonella, Shigella, and Campylobacter. To ensure the accuracy and reliability of the assay, it is crucial to include appropriate controls. Which of the following sets of controls would be MOST comprehensive?

• A. Positive controls for each target organism and a negative control without any template DNA.
• B. Positive controls for each target organism, a negative control without template DNA, an internal amplification control, and a process control to monitor nucleic acid extraction.
• C. Positive controls for each target organism, a negative control containing non-target DNA, and a process control to monitor nucleic acid extraction.
• D. Positive controls for each target organism, a negative control without template DNA, and an internal amplification control.

A patient develops a severe skin and soft tissue infection following a boating accident in the Gulf Coast.
Wound cultures grow a Gram-negative, halophilic bacterium that is oxidase-positive. The MOST likely organism is:

• A. Vibrio vulnificus
• B. Aeromonas hydrophila
• C. Shewanella putrefaciens
• D. Pseudomonas aeruginosa